课题基金 / 基金详情

Clinical Impact of Oncomine Myeloid Targeted DNA Sequencing Assay for Patients with Hematological Disorders

Clinical Impact of Oncomine Myeloid Targeted DNA Sequencing Assay for Patients with Hematological Disorders
Oncomine 骨髓靶向 DNA 测序分析对血液疾病患者的临床影响
批准号：
400222
负责人：
Ferrone Christina
金额：
$0.1万
依托单位：
Queen's University (Kingston, Ontario)
依托单位国家：
加拿大
项目类别：
财政年份：
2019
资助国家：
加拿大
项目状态：
已结题
起止时间：
2019-01-01 至 2020-01-01
来源：
https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=400222&lang=en
关键词：
Myeloid Cancers

项目摘要

项目成果

Ferrone Christina的其他基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
In recent years, the significance of genetic information in the diagnosis, screening, and treatment of myeloid (blood) cancers has become highly evident. The increasing impact of identifying genes associated with these cancers necessitates more comprehens
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
The clinical impact of next-generation sequencing on myeloid malignancies
  • 批准号：
    440022
  • 项目类别：
    Studentship Programs
  • 资助金额：
    $7.65万
  • 财政年份：
    2020
  • 负责人：
    Ferrone Christina
  • 依托单位：
    Queen's University (Kingston, Ontario)
Validation and Clinical Impact of the Oncomine Myeloid Targeted DNA and RNA Ion Semiconductor Sequencing Assay